Literature DB >> 26601069

Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1.

Maxi Cöster1, Heike Biebermann2, Torsten Schöneberg1, Claudia Stäubert1.   

Abstract

OBJECTIVES: The trace amine-associated receptor 1 (Taar1) is a Gs protein-coupled receptor activated by trace amines, such as β-phenylethylamine (β-PEA) and 3-iodothyronamine (T1AM). T1AM is an endogenous biogenic amine and thyroid hormone derivative that exerts several biological functions. However, the physiological relevance of T1AM acting via Taar1 is still under discussion. Therefore, we studied the structural and functional evolution of Taar1 in vertebrates to provide evidence for a conserved Taar1-mediated T1AM function. STUDY
DESIGN: We searched public sequence databases to retrieve Taar1 sequence information from vertebrates. We cloned and functionally characterized Taar1 from selected vertebrate species using cAMP assays to determine the evolutionary conservation of T1AM action at Taar1.
RESULTS: We found intact open reading frames of Taar1 in more than 100 vertebrate species, including mammals, sauropsids and amphibians. Evolutionary conservation analyses of Taar1 protein sequences revealed a high variation in amino acid residues proposed to be involved in agonist binding, especially in rodent Taar1 orthologs. Functional characterization showed that T1AM, β-PEA and p-tyramine (p-Tyr) act as agonists at all tested orthologs, but EC50 values of T1AM at rat Taar1 differed significantly when compared to all other tested vertebrate Taar1.
CONCLUSIONS: The high structural conservation of Taar1 throughout vertebrate evolution highlights the physiological relevance of Taar1, but species-specific differences in T1AM potency at Taar1 orthologs suggest a specialization of rat Taar1 for T1AM recognition. In contrast, β-PEA and p-Tyr potencies were rather conserved throughout all tested Taar1 orthologs. We provide evidence that the observed differences in potency are related to differences in constraint during Taar1 evolution.

Entities:  

Keywords:  3-Iodothyronamine; Trace amine-associated receptor 1; Vertebrates; p-Tyramine; β-Phenylethylamine

Year:  2015        PMID: 26601069      PMCID: PMC4640299          DOI: 10.1159/000430839

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  41 in total

1.  HPLC electrochemical detection of trace amines in human plasma and platelets and expression of mRNA transcripts of trace amine receptors in circulating leukocytes.

Authors:  Giovanni D'Andrea; Salvatore Terrazzino; Dino Fortin; Angelo Farruggio; Luciano Rinaldi; Alberta Leon
Journal:  Neurosci Lett       Date:  2003-07-31       Impact factor: 3.046

2.  The rapid generation of mutation data matrices from protein sequences.

Authors:  D T Jones; W R Taylor; J M Thornton
Journal:  Comput Appl Biosci       Date:  1992-06

3.  Evaluation of an improved branch-site likelihood method for detecting positive selection at the molecular level.

Authors:  Jianzhi Zhang; Rasmus Nielsen; Ziheng Yang
Journal:  Mol Biol Evol       Date:  2005-08-17       Impact factor: 16.240

4.  Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors.

Authors:  Lothar Lindemann; Martin Ebeling; Nicole A Kratochwil; James R Bunzow; David K Grandy; Marius C Hoener
Journal:  Genomics       Date:  2005-03       Impact factor: 5.736

5.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

6.  Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.

Authors:  J R Bunzow; M S Sonders; S Arttamangkul; L M Harrison; G Zhang; D I Quigley; T Darland; K L Suchland; S Pasumamula; J L Kennedy; S B Olson; R E Magenis; S G Amara; D K Grandy
Journal:  Mol Pharmacol       Date:  2001-12       Impact factor: 4.436

7.  Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1.

Authors:  David B Wainscott; Sheila P Little; Tinggui Yin; Yuan Tu; Vincent P Rocco; John X He; David L Nelson
Journal:  J Pharmacol Exp Ther       Date:  2006-10-12       Impact factor: 4.030

8.  Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.

Authors:  Helen N Panas; Laurie J Lynch; Eric J Vallender; Zhihua Xie; Guo-Lin Chen; Spencer K Lynn; Thomas S Scanlan; Gregory M Miller
Journal:  J Neurosci Res       Date:  2010-07       Impact factor: 4.164

9.  Identification and characterization of 3-iodothyronamine intracellular transport.

Authors:  Alexandra G Ianculescu; Kathleen M Giacomini; Thomas S Scanlan
Journal:  Endocrinology       Date:  2008-12-12       Impact factor: 4.736

10.  V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms.

Authors:  T Schöneberg; A Schulz; H Biebermann; A Grüters; T Grimm; K Hübschmann; G Filler; T Gudermann; G Schultz
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

View more
  7 in total

Review 1.  Novel thyroid hormones.

Authors:  Riccardo Zucchi; Grazia Rutigliano; Federica Saponaro
Journal:  Endocrine       Date:  2019-07-20       Impact factor: 3.633

Review 2.  Thyroid Dysfunction and Heart Failure: Mechanisms and Associations.

Authors:  Hernando Vargas-Uricoechea; Anilza Bonelo-Perdomo
Journal:  Curr Heart Fail Rep       Date:  2017-02

Review 3.  Torpor: The Rise and Fall of 3-Monoiodothyronamine from Brain to Gut-From Gut to Brain?

Authors:  Hartmut H Glossmann; Oliver M D Lutz
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-31       Impact factor: 5.555

4.  Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders.

Authors:  Grazia Rutigliano; Julia Bräunig; Claudia Del Grande; Vittoria Carnicelli; Isabella Masci; Sergio Merlino; Gunnar Kleinau; Luca Tessieri; Simone Pardossi; Sarah Paisdzior; Liliana Dell'Osso; Heike Biebermann; Riccardo Zucchi
Journal:  Front Pharmacol       Date:  2019-09-13       Impact factor: 5.810

Review 5.  The Case for TAAR1 as a Modulator of Central Nervous System Function.

Authors:  Grazia Rutigliano; Alice Accorroni; Riccardo Zucchi
Journal:  Front Pharmacol       Date:  2018-01-10       Impact factor: 5.810

Review 6.  3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?

Authors:  Grazia Rutigliano; Lavinia Bandini; Simona Sestito; Grazia Chiellini
Journal:  Int J Mol Sci       Date:  2020-03-15       Impact factor: 5.923

7.  Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia.

Authors:  Michele L R Heffernan; Lee W Herman; Scott Brown; Philip G Jones; Liming Shao; Michael C Hewitt; John E Campbell; Nina Dedic; Seth C Hopkins; Kenneth S Koblan; Linghong Xie
Journal:  ACS Med Chem Lett       Date:  2021-12-06       Impact factor: 4.345

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.